|61.35||-5.15 / -7.74%|
Data as of 3:59pm ET
|61.35||0.00 / 0.00%|
The 4 analysts offering 12-month price forecasts for Agios Pharmaceuticals Inc have a median target of 62.50, with a high estimate of 75.00 and a low estimate of 58.00. The median estimate represents a +1.87% increase from the last price of 61.35.
The current consensus among 5 polled investment analysts is to Buy stock in Agios Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.